General Information of the Compound
Compound ID
CP0081736
Compound Name
5-[3-[3-(3,5-dimethylpyrazol-1-yl)azetidin-1-yl]propyl]-3-phenyl-1,2,4-oxadiazole
    Show/Hide
Structure
Formula
C19H23N5O
Molecular Weight
337.427
Canonical SMILES
Cc1cc(C)n(n1)C1CN(CCCc2nc(no2)-c2ccccc2)C1
    Show/Hide
InChI
InChI=1S/C19H23N5O/c1-14-11-15(2)24(21-14)17-12-23(13-17)10-6-9-18-20-19(22-25-18)16-7-4-3-5-8-16/h3-5,7-8,11,17H,6,9-10,12-13H2,1-2H3
    Show/Hide
InChIKey
ZQOMSSAVWGLZSB-UHFFFAOYSA-N
Physicochemical Property
logP
3.03944
Rotatable Bonds
6
Heavy Atom Count
25
Polar Areas
59.98
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
6
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 56781741
ChEMBL ID
CHEMBL4169603
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01206, Histamine H1 receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 2683 nM
   TI
   LI
   LO
   TS